Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation

Stephan Pallua(Innsbruck Medical University), Bernhard Holzner(Innsbruck Medical University), Anne Oberguggenberger(Innsbruck Medical University), Martin Kopp(Innsbruck Medical University), David Nachbaur(Innsbruck Medical University), Johannes Clausen(Innsbruck Medical University), Barbara Sperner‐Unterweger(Innsbruck Medical University), Georg Kemmler(Innsbruck Medical University), Johannes M. Giesinger(Innsbruck Medical University)
Bone Marrow Transplantation
March 15, 2010
10.1038/bmt.2010.5
Cited by 103

Related Papers

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
|Blood|2010|485
General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States
|European Journal of Cancer|2018|467
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
|Blood|2014|400
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
|Journal of Clinical Oncology|2011|393